| Filed On | Filing |
|---|---|
| 24 Sep 2026 | Form 3: MacLeod Alan Robert, Chief Scientific Officer |
| 24 Sep 2026 |
Form 3: Zhu Rui (NMN), Chief Technology Officer
Holds 2,511,943 shares of Common Stock |
| 24 Sep 2026 | Form 3: Ackles Robert William, Chief People Officer |
| 24 Sep 2026 | Form 3: Fisk Ryan, CFO and CBO |
| 24 Sep 2026 | Form 3: Huang Ying, Director |
| 24 Sep 2026 |
Form 3: Li Zhen, Director
Holds 5,861,199 shares of Common Stock |
| 24 Sep 2026 | Form 3: Chimovits Erez, Director |
| 24 Sep 2026 | Form 3: Tagliaferri Mary, Director |
| 24 Sep 2026 | Form 3: Orbimed Advisors Llc, Director and 3 others |
| 24 Sep 2026 | Form 3: Gordon Carl L, Director |
| 24 Sep 2026 | Form 3: Lav Biosciences Fund V, L.p., 10% owner and 2 others |
| 24 Sep 2026 | Form 3: George Simeon, Director |
| 24 Sep 2026 | Form 3: Sr One Capital MANAGEMENT, Llc, 10% owner |
Loading...
